Lancashire and South Cumbria
Formulary
Formulary
4 Central nervous system
04-10-03 Opioid-receptor antagonists
| Naltrexone hydrochloride |
|
Formulary
|
Tablets 50mg Test for opioid dependence with naloxone before treatment. Under expert supervision. |
 NICE TA115: Naltrexone for the management of opioid dependence |
|
Links
Gabapentinoid (pregabalin and gabapentin):De-prescribing guidance for non-cancer pain in adults in primary care - LSCMMG Paracetamol – prescribing weight-adjusted paracetamol in adults in the community
- LSCMMG: ADHD combined adult and child shared care guideline
- LSCMMG: Opioid reduction: best interests opioid reduction position statement
- LSCMMG: Opioid treatment: patient-prescriber opioid treatment agreement
- LSCMMG: Restless Legs Syndrome in Adults in Primary Care
- MHRA Drug Safety Update Jan 2020: E-cigarette use or vaping: reporting suspected adverse reactions, including lung injury
- MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression
- MHRA: Opioids: risk of dependence and addiction
- NICE CG52: Drug misuse in over 16s: opioid detoxification
- NICE TA114: Methadone and buprenorphine for the management of opioid dependence
- NICE TA114: Methadone and buprenorphine for the management of opioid dependence
- NICE TA114: Methadone and buprenorphine for the management of opioid dependence
- NICE TA114: Methadone and buprenorphine for the management of opioid dependence
- NICE TA115: Drug misuse - naltrexone
- NICE TA115: Naltrexone for the management of opioid dependence